Bookmark and Share

Compound Summary for: CID 3062316

dasatinib

Also known as: Sprycel; 302962-49-8; BMS-354825; BMS 354825; BMS354825; dasatinibum; Spyrcel; UNII-X78UG0A0RN; Dasatinib anhydrous
Molecular Formula: C22H26ClN7O2S   Molecular Weight: 488.00554   InChIKey: ZBNZXTGUTAYRHI-UHFFFAOYSA-N
Dasatinib is an oral dual BCR/ABL and Src family tyrosine kinase inhibitor approved for use in patients with chronic myelogenous leukemia (CML). The main targets of Dasatinib, are BCRABL, SRC, Ephrins and GFR.   From: DrugBank
Show subcontent titlesTable of Contents
Identification
Related Records
show all 3 sub-sections (Related Compounds with Annotation, Related Compounds, Related Substances)
Use and Manufacturing
Pharmacology
Literature
Patents
Biomolecular Interactions and Pathways
Biological Test Results
Classification
Chemical and Physical Properties
_ _